D-Index & Metrics Best Publications
Medicine
Japan
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 110 Citations 48,720 898 World Ranking 3213 National Ranking 62

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Japan Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Cancer

His primary areas of study are Internal medicine, Stroke, Cohort study, Risk factor and Prospective cohort study. His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus and Endocrinology. His Stroke study incorporates themes from Epidemiology, Surgery, Vascular disease, Disease and Hazard ratio.

His Cohort study research includes elements of Overweight, Food science, Gerontology and Environmental health. His Risk factor research focuses on Incidence and how it connects with Myocardial infarction and Heart disease. His study in Prospective cohort study is interdisciplinary in nature, drawing from both Odds ratio, Physiology and Intraparenchymal hemorrhage.

His most cited work include:

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (956 citations)
  • Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial (936 citations)
  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction (702 citations)

What are the main themes of his work throughout his whole career to date?

Hiroyasu Iso spends much of his time researching Internal medicine, Prospective cohort study, Cohort study, Stroke and Hazard ratio. His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Cardiology. The various areas that he examines in his Prospective cohort study study include Incidence, Intraparenchymal hemorrhage, Lower risk, Public health and Cohort.

His studies deal with areas such as Cancer, Gerontology, Environmental health, Relative risk and Obstetrics as well as Cohort study. His Stroke study combines topics from a wide range of disciplines, such as Coronary heart disease, Surgery, Epidemiology, Disease and Physical therapy. The Hazard ratio study combines topics in areas such as Risk of mortality and Proportional hazards model.

He most often published in these fields:

  • Internal medicine (54.24%)
  • Prospective cohort study (32.45%)
  • Cohort study (33.00%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (54.24%)
  • Cohort study (33.00%)
  • Prospective cohort study (32.45%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Cohort study, Prospective cohort study, Hazard ratio and Confidence interval. His Internal medicine study frequently involves adjacent topics like Cardiology. His work carried out in the field of Cohort study brings together such families of science as Body mass index, Cancer, Incidence, Environmental health and Obstetrics.

As a part of the same scientific family, Hiroyasu Iso mostly works in the field of Prospective cohort study, focusing on Pregnancy and, on occasion, Autism. His Hazard ratio research is multidisciplinary, relying on both Absolute risk reduction, Diabetes mellitus, Lower risk, Proportional hazards model and Confounding. The Stroke study which covers Disease that intersects with Epidemiology and Global health.

Between 2018 and 2021, his most popular works were:

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (224 citations)
  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (224 citations)
  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (224 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

Hiroyasu Iso focuses on Prospective cohort study, Cohort study, Internal medicine, Stroke and Hazard ratio. His Prospective cohort study study combines topics in areas such as Cause specific mortality, Proportional hazards model, Linear regression and Medical record. Hiroyasu Iso combines subjects such as Incidence, Environmental health, Adverse effect, Public health and Type 2 diabetes with his study of Cohort study.

His work investigates the relationship between Internal medicine and topics such as Alcohol that intersect with problems in Social support. Hiroyasu Iso has researched Stroke in several fields, including Coronary heart disease, Intraparenchymal hemorrhage, Blood pressure, Disease and Myocardial infarction. His work in Hazard ratio addresses issues such as Risk of mortality, which are connected to fields such as Aneurysm, Aortic aneurysm and Kidney disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Theo Vos;Theo Vos;Theo Vos;Stephen S. Lim;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati;Kaja M. Abbas;Kaja M. Abbas;Kaja M. Abbas.
(2020)

3149 Citations

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Christopher J.L. Murray;Christopher J.L. Murray;Christopher J.L. Murray;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Peng Zheng;Peng Zheng;Peng Zheng;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati.
(2020)

1916 Citations

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

Hiroyasu Iso;David R. Jacobs;Deborah Wentworth;James D. Neaton.
The New England Journal of Medicine (1989)

1517 Citations

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

J Danesh;S Lewington;S G Thompson;Lowe Gdo..
JAMA (2005)

1487 Citations

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood.
The New England Journal of Medicine (2012)

1143 Citations

Report of the Conference on Low Blood Cholesterol: Mortality Associations.

D Jacobs;H Blackburn;M Higgins;D Reed.
Circulation (1992)

866 Citations

Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I.

Hiroyasu Iso;Minatsu Kobayashi;Junko Ishihara;Satoshi Sasaki.
Circulation (2006)

750 Citations

Intake of fish and omega-3 fatty acids and risk of stroke in women.

Hiroyasu Iso;Kathryn M. Rexrode;Meir J. Stampfer;JoAnn E. Manson.
JAMA (2001)

703 Citations

Association of Cardiometabolic Multimorbidity With Mortality

Emanuele Di Angelantonio;Stephen Kaptoge;David Wormser;Peter Willeit.
JAMA (2015)

596 Citations

The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults

Hiroyasu Iso;Hiroyasu Iso;Chigusa Date;Chigusa Date;Kenji Wakai;Mitsuru Fukui.
Annals of Internal Medicine (2006)

577 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hiroyasu Iso

Tomonori Okamura

Tomonori Okamura

Keio University

Publications: 202

Hirotsugu Ueshima

Hirotsugu Ueshima

Shiga University of Medical Science

Publications: 183

Shoichiro Tsugane

Shoichiro Tsugane

National Cancer Research Institute, UK

Publications: 143

Katsuyuki Miura

Katsuyuki Miura

Shiga University of Medical Science

Publications: 135

Mark Woodward

Mark Woodward

Imperial College London

Publications: 110

Akiko Tamakoshi

Akiko Tamakoshi

Hokkaido University

Publications: 109

Takayoshi Ohkubo

Takayoshi Ohkubo

Teikyo University

Publications: 106

Manami Inoue

Manami Inoue

University of Tokyo

Publications: 97

Frank B. Hu

Frank B. Hu

Harvard University

Publications: 94

Kenji Wakai

Kenji Wakai

Nagoya University

Publications: 86

Ichiro Tsuji

Ichiro Tsuji

Tohoku University

Publications: 85

Tetsuya Mizoue

Tetsuya Mizoue

Kyushu University

Publications: 74

Gordon D.O. Lowe

Gordon D.O. Lowe

University of Glasgow

Publications: 71

JoAnn E. Manson

JoAnn E. Manson

Harvard Medical School

Publications: 65

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 64

Motoki Iwasaki

Motoki Iwasaki

National Cancer Research Institute, UK

Publications: 62

Trending Scientists

Begoña Calvo

Begoña Calvo

University of Zaragoza

bahman naderi

bahman naderi

University of Windsor

Vladimir Zolotov

Vladimir Zolotov

IBM (United States)

Leopoldo Zelante

Leopoldo Zelante

Casa Sollievo della Sofferenza

Orit Kollet

Orit Kollet

Weizmann Institute of Science

Jérôme Guicheux

Jérôme Guicheux

University of Nantes

Igor Mokrousov

Igor Mokrousov

Institut Pasteur

Michael A. Beaven

Michael A. Beaven

National Institutes of Health

Shang-Tzen Chang

Shang-Tzen Chang

National Taiwan University

J. Maxwell Dow

J. Maxwell Dow

University College Cork

Peter L. Molloy

Peter L. Molloy

Commonwealth Scientific and Industrial Research Organisation

James K. Fredrickson

James K. Fredrickson

Pacific Northwest National Laboratory

James W. Hurrell

James W. Hurrell

Colorado State University

Sven Jarius

Sven Jarius

Heidelberg University

Bård Kuvaas

Bård Kuvaas

BI Norwegian Business School

Bryan Kestenbaum

Bryan Kestenbaum

University of Washington

Something went wrong. Please try again later.